Blood diseases

Leukemia, Lymphoma, Beta thalassemia

Cell & Gene Therapy Clinical Phase 1 Autoimmune diseases Cancer Diagnosis & Therapy

CAR T-Cell Therapy for Leukemia and Lymphoma

PI: Prof. Nguyen Thanh Liem; Co-PI: Assc. Prof. Bach Quoc Khanh

This Phase I clinical trial aims to evaluate the safety and efficacy of single-dose anti-CD19 CAR T-cell therapy in patients with relapsed or refractory CD19+ non-Hodgkin lymphoma and acute lymphoblastic leukemia

Blood diseases Clinical Phase 1 Cell & Gene Therapy

Edited-CD34+ cells for treatment of Beta thalassemia

PI: Dr. Dao Thi Mai Lan; Co-PI: Assc. Prof. Bach Quoc Khanh

Automated generation of CRISPR-Cas9 gene-edited CD34+ cells for clinical treatment of Beta thalassemia (VINIF.DA139)